| 16.02.2021 |
International Coalition of Medicines Regulatory Agencies (ICMRA) Statements with Participation of the Paul-Ehrlich-Institut |
| 29.12.2020 |
Corona Vaccination in Individuals Suffering from Allergies |
| 22.12.2020 |
Observation of the Spread of a Virus Variant of SARS-CoV-2 in the United Kingdom |
| 14.12.2020 |
Statement: Pyrogen Testing on Rabbits |
| 13.11.2020 |
Information on the Development Status of COVID-19 Vaccines |
| 10.09.2020 |
Statement: Clinical Trial of AstraZeneca put on hold |
| 12.08.2020 |
Statement: Regulatory Approval in Russia of a COVID-19 Vaccine Developed by Gamaleya Institute |
| 10.03.2020 |
Exclusion from donating Blood |
| 07.01.2020 |
Joint Letter by the EC, EMA and HMA - Provision of Results for Authorised Clinical Trials in EudraCT (June 2019) |
| 27.05.2019 |
Statement by the Scientific Advisory Board of the Paul-Ehrlich-Institut on the Quality and Safety of Vaccines (German Only) |
| 21.11.2019 |
Position of Paul-Ehrlich-Institut Regarding the Use of Biosimilars |
